Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Caroline, a CIDP patient, created a canvas of light and hope to capture the treatment phase.
An end to confusion: CIDP patient Darryl paints the relief of diagnosis.
Watch a short animation about teaching kids to self-infuse.
Biotech CSL Behring unveils expansion plans in Marburg.
Mentors can help guide young sickle cell disease patients.
Tell your healthcare team about physical limitations, says CIDP patient Elizabeth Thirtyacre.
One mom’s advice for launching a successful fundraising campaign.
Film recalls a son lost to primary immunodeficiency and the legacy built in his name.
Our animation explains the rare blood disorder and what CSL Behring is doing to help.
Here’s why thousands of biotech leaders flock to the global meetup.
A Q & A with Chief Communications Officer Anthony Farina.
Founders of Jeffrey Modell Foundation discuss new documentary on "World of Promise."
Americas
Asia Pacific
Middle East
Europe
